日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PROMISE‑MINO: A Prospective, Open‑Label, Multicenter, Single‑Arm, Phase IV Study of the Safety, Local Tolerability, and Efficacy of Topical Minocycline Hydrochloride 4% Gel in Indian Patients With Moderate‑to‑Severe Acne Vulgaris

PROMISE-MINO:一项前瞻性、开放标签、多中心、单臂 IV 期研究,旨在评估 4% 盐酸米诺环素凝胶外用治疗印度中重度寻常痤疮患者的安全性、局部耐受性和疗效。

Viswanath, Vishalakshi; Pradhan, Swetalina; Bhura, Mamta; Gupta, Richa; Suryatale, Prerna; Banguru, H; De, Abhishek; Sonkar, Vijay; Bhushan, Sumit; Gadkari, Rujuta; Dhoot, Dhiraj; Balasubramanian, Ashwin; Patil, Saiprasad; Barkate, Hanmant